Ir al contenido

Targets and Emerging Therapies for Schizophrenia
Foto de archivo: la portada puede ser diferente

Targets and Emerging Therapies for Schizophrenia Open ebook - 2012

de Jeffrey S. Albert (Editor); Michael W. Wood (Editor)

Detalles

  • Título Targets and Emerging Therapies for Schizophrenia
  • Autor Jeffrey S. Albert (Editor); Michael W. Wood (Editor)
  • Encuadernación Open Ebook
  • Páginas 486
  • Volúmenes 1
  • Idioma ENG
  • Editorial Wiley
  • Fecha de publicación 2012
  • ISBN 9781118309384 / 1118309383
  • Library of Congress subjects Schizophrenia - drug therapy
  • Número de catálogo de la Librería del Congreso de EEUU 2011052987
  • Dewey Decimal Code 616.898

Acerca del autor

JEFFREY S. ALBERT, PhD, is a Project Leader and Head of Lead Generation Chemistry in AstraZeneca's neuroscience department. He has authored or coauthored more than forty publications, mostly focusing on novel therapeutic targets involved in depression, schizophrenia, and Alzheimer's disease and on the development and application of fragment-based lead generation methodologies.

MICHAEL W. WOOD, PhD, is an External Collaborations Director in AstraZeneca's neuroscience unit where he is responsible for coordinating research to deliver novel therapeutics targeting schizophrenia as well as other neuroscience treatments. He has been focused on neuroscience drug discovery research for fifteen years.

Espera... estamos cargando la página solicitada.